CAS: 50443-60-2; Revefenacin Impurity 9

结构式图片

相似化合物

14925-09-8 6301-18-4 1087788-51-9

MSDS等安全信息

    合成工艺路线路线简述

      📜5-((1R)-2-Amino-1-{[Tert-Butyl(Dimethyl)Silyl]Oxy}Ethyl)-8-Hydroxyquinolin-2(1H)-One Acetate,三乙酰氧基硼氢化钠,二氯甲烷 在 水体系中,用 甲醇作为反应溶剂,反应 16.5H,获得 Biphenyl-2-Ylcarbamic Acid
      参考文献:Biphenyl Derivatives
      标题:Biphenyl Derivatives
      摘要:本发明提供了式i的双苯基衍生物:其中r1,R2,R3,R4,R5,R6,R7,W,A,B和c如规范中所定义,或其药学上可接受的盐,溶剂或立体异构体.本发明的双苯基衍生物具有β2肾上腺素能受体激动剂和毒蕈碱受体拮抗剂活性,因此,这种双苯基衍生物可用于治疗肺部疾病,如慢性阻塞性肺疾病和哮喘.

      海关参考信息

      专利信息


      专利号:US-9035061-B2
      优先权日:2010-07-13
      标题:Process for preparing a biphenyl-2-ylcarbamic acid
      发明人:COLSON PIERRE-JEAN
      权利人:COLSON PIERRE-JEAN; THERAVANCE BIOPHARMA R & D IP LLC
      摘要:The invention provides a process of preparing an intermediate useful in the synthesis of biphenyl-2-ylcarbamic acid 1-(2-{[4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino}ethyl)piperidin-4-yl ester, and a process of preparing a crystalline freebase of the ester.

      专利号:EP-1930323-A1
      优先权日:2004-03-11
      标 题:Biphenyl compounds useful in the synthesis of muscarinic receptor antagonists

      专利号:ES-2345640-T3
      优先权日:2004-03-11
      标 题 :USEFUL BIFENYL COMPOUNDS IN THE SYNTHESIS OF ANTAGONISTS OF THE MUSCARINIC RECEPTOR

      专利号:EP-1930323-B1
      优先权日:2004-03-11
      标 题:Biphenyl compounds useful in the synthesis of muscarinic receptor antagonists

      专利号:WO-0056709-A1
      优先权日:1999-03-24
      标 题:Indolinone compounds as kinase inhibitors
      发明人:TANG PENG CHO; SUN LI; MCMAHON GERALD; MILLER TODD ANTHONY; SHIRAZIAN SHAHRZAD; WEI CHUNG CHEN; HARRIS G DAVIS; XIAOYUAN LI; LIANG CONGXIN
      权利人:SUGEN INC; TANG PENG CHO; SUN LI; MCMAHON GERALD; MILLER TODD ANTHONY; SHIRAZIAN SHAHRZAD; WEI CHUNG CHEN; HARRIS G DAVIS; XIAOYUAN LI; LIANG CONGXIN
      摘要:The invention relates to certain indolinone compounds, their method of synthesis, and a combinatorial library consisting of the indolinone compounds of the invention. The invention also relates to methods of modulating the function of protein kinases using indolinone compounds of the invention and methods of treating diseases by modulating the function of protein kinases and related signal transduction pathways.

      专利号:US-6689806-B1
      优先权日:1999-03-24
      标 题 :Indolinone compounds as kinase inhibitors
      发明人:TANG PENG CHO; SUN LI; MCMAHON GERALD; MILLER TODD ANTHONY; SHIRAZIAN SHAHRZAD; WEI CHUNG CHEN; HARRIS JR G DAVIS; LI XIAOYUAN; LIANG CONGXIN
      权利人:SUGEN INC
      摘要:The invention relates to certain indolinone compounds, their method of synthesis, and a combinatorial library consisting of the indolinone compounds of the invention. The invention also relates to methods of modulating the function of protein kinases using indolinone compounds of the invention and methods of treating diseases by modulating the function of protein kinases and related signal transduction pathways.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献


      参考文献:10.1517/13543776.16.9.1315|10.1517/13543776.16.9.1321
      摘要:Norman P. Long-acting muscarinic M3receptor antagonists. Expert Opinion on Therapeutic Patents. 2006 Aug 31;16(9):1315–20. doi: 10.1517/13543776.16.9.1315.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知